Presentation is loading. Please wait.

Presentation is loading. Please wait.

Samuel S. Ahn, MD, David E. Williams, BA, Dirk A

Published byΚλεόπας Μελετόπουλος Modified over 5 years ago

Similar presentations

Presentation on theme: "Samuel S. Ahn, MD, David E. Williams, BA, Dirk A"— Presentation transcript:

1 The isolation of a fibroblast growth inhibitor associated with perigraft seroma 
Samuel S. Ahn, MD, David E. Williams, BA, Dirk A. Thye, BA, Karen Qi Cheng, PhD, David A. Lee, MD  Journal of Vascular Surgery  Volume 20, Issue 2, Pages (August 1994) DOI: / (94) Copyright © 1994 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

2 Fig. 1 A, Fibroblast growth response to increasing concentrations of normal human serum (NHS), serum from patient with perigraft seroma around PTFE axillo-femoral graft (PGS I), serum from patient with perigraft seroma around PTFE femoropopliteal graft (PGS II) and serum from this latter patient 6 months after graft removal and seroma resolution. Measured by [3H] thymidine assay. B, Fibroblast growth response with same serum samples as described in Fig. 1, A. Measured by hexosaminidase colorimetric assay. Journal of Vascular Surgery  , DOI: ( / (94) ) Copyright © 1994 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

3 Fig. 1 A, Fibroblast growth response to increasing concentrations of normal human serum (NHS), serum from patient with perigraft seroma around PTFE axillo-femoral graft (PGS I), serum from patient with perigraft seroma around PTFE femoropopliteal graft (PGS II) and serum from this latter patient 6 months after graft removal and seroma resolution. Measured by [3H] thymidine assay. B, Fibroblast growth response with same serum samples as described in Fig. 1, A. Measured by hexosaminidase colorimetric assay. Journal of Vascular Surgery  , DOI: ( / (94) ) Copyright © 1994 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

4 Fig. 2 Fibroblast growth response to 50% test serum with same samples as described in Fig. 1, A. Measured by [3H] thymidine assay. Journal of Vascular Surgery  , DOI: ( / (94) ) Copyright © 1994 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

5 Fig. 3 Fibroblast growth response to PGS II fractions at 20% of well volume. Measured with [3H] thymidine assay Journal of Vascular Surgery  , DOI: ( / (94) ) Copyright © 1994 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

6 Fig. 4 Fibroblast growth response to normal human serum fractions at 20% of well volume. Measured with [3H] thymidine assay. Journal of Vascular Surgery  , DOI: ( / (94) ) Copyright © 1994 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

7 Fig. 5 Fibroblast growth response to uninfected and infected graft serum fractions at 50% of well volume. Measured with [3H] thymidine assay. Journal of Vascular Surgery  , DOI: ( / (94) ) Copyright © 1994 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

Download ppt "Samuel S. Ahn, MD, David E. Williams, BA, Dirk A"

Similar presentations

Endothelial cell seeding reduces thrombogenicity of Dacron grafts in humans Per Örtenwall, MD, PhD *, Hans Wadenvik, MD, PhD **, Jack Kutti, MD, PhD **,

Endothelial cell seeding reduces thrombogenicity of Dacron grafts in humans Per Örtenwall, MD, PhD *, Hans Wadenvik, MD, PhD **, Jack Kutti, MD, PhD **,
The role of arteriovenous shunts in the pathogenesis of varicose veins Howard C. Baron, M.D., Sebastiano Cassaro, M.D. Journal of Vascular Surgery Volume.

The role of arteriovenous shunts in the pathogenesis of varicose veins Howard C. Baron, M.D., Sebastiano Cassaro, M.D. Journal of Vascular Surgery Volume.
The effect of inguinal lymphatic manipulation on regional lymph flow patterns Jeffrey R. Rubin, MD, Lisa B. Eberlin, MD Journal of Vascular Surgery Volume.

The effect of inguinal lymphatic manipulation on regional lymph flow patterns Jeffrey R. Rubin, MD, Lisa B. Eberlin, MD Journal of Vascular Surgery Volume.
A review of 100 consecutive reconstructions of the distal vertebral artery for embolic and hemodynamic disease  Ramon Berguer, MD, PhD, Mark D. Morasch,

A review of 100 consecutive reconstructions of the distal vertebral artery for embolic and hemodynamic disease  Ramon Berguer, MD, PhD, Mark D. Morasch,
Clinical evaluation of recombinant human platelet – derived growth factor for the treatment of lower extremity diabetic ulcers  David L. Steed, MD, the.

Clinical evaluation of recombinant human platelet – derived growth factor for the treatment of lower extremity diabetic ulcers  David L. Steed, MD, the.
Heparin-coated catheters and heparin-induced thrombocytopenia

Heparin-coated catheters and heparin-induced thrombocytopenia
Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.
Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease  Samuel R. Money, MD, J.Alan.

Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease  Samuel R. Money, MD, J.Alan.
Richard T. Purdy, M. D. , Frederick C. Beyer, M. D. , William D

Richard T. Purdy, M. D. , Frederick C. Beyer, M. D. , William D
Creation and closure of temporary arteriovenous fistulas for venous reconstruction or thrombectomy: Description of technique  Richard J. Sanders, M.D.,

Creation and closure of temporary arteriovenous fistulas for venous reconstruction or thrombectomy: Description of technique  Richard J. Sanders, M.D.,
Surgical management of infected abdominal aortic grafts: Review of a 25-year experience  Patrick J. O'Hara, M.D., Norman R. Hertzer, M.D., Edwin G. Beven,

Surgical management of infected abdominal aortic grafts: Review of a 25-year experience  Patrick J. O'Hara, M.D., Norman R. Hertzer, M.D., Edwin G. Beven,
A new valvulotome for in situ bypass grafts

A new valvulotome for in situ bypass grafts
Computed electroencephalographic topographic brain mapping

Computed electroencephalographic topographic brain mapping
Jeffrey R. Rubin, M.D., James M. Malone, M.D., Jerry Goldstone, M.D. 

Jeffrey R. Rubin, M.D., James M. Malone, M.D., Jerry Goldstone, M.D. 
Axillofemoral bypass: A tool with a limited role

Axillofemoral bypass: A tool with a limited role
Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease  Samuel R. Money, MD, J.Alan.

Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease  Samuel R. Money, MD, J.Alan.
Malcolm O. Perry, MD, Richard Kempczinski, MD 

Malcolm O. Perry, MD, Richard Kempczinski, MD 
Recurrent thoracic outlet syndrome

Recurrent thoracic outlet syndrome
The management of massive ultrafiltration distending the aneurysm sac after abdominal aortic aneurysm repair with a polytetrafluoroethylene aortobiiliac.

The management of massive ultrafiltration distending the aneurysm sac after abdominal aortic aneurysm repair with a polytetrafluoroethylene aortobiiliac.
Antibacterial activity, antibiotic retention, and infection resistance of a rifampin- impregnated gelatin-sealed Dacron graft  Kevin Lachapelle, MD, Alan.

Antibacterial activity, antibiotic retention, and infection resistance of a rifampin- impregnated gelatin-sealed Dacron graft  Kevin Lachapelle, MD, Alan.

Similar presentations

Ads by Google